Dyslipidemia correction by polychemotherapy treatment in patients with Hodgkin lymphoma and non-Hodgkin malignant lymphomas

1. Kazyulin A.N., Velsher L.Z., Queen I.A. et al. Cardiotoxicity during chemotherapy of cancer // Critical care medicine. 2010/ (1) 62-70. (in Russian)

2. Matyas M.G., Kravchuk T.L., Vysotsky V.V. et al. Non-anthracycline cardiotoxicity // Siberian Journal of Oncology. 2009. (5). 73-82. (in Russian)

3. Pat. 2144360 RF. Cholesterol-lowering drugs / Panin L.E., Dushkin M.I. .; publ. 20.01.2000. (in Russian)

4. Pat. 2135188 RF. Drug with regenerative - reducing effect / Panin L.E., Ubasheev I.O.; publ. 27.08.1999. (in Russian)

5. Pospelova T.I., Soldatova G.S., Ageeva T.A., Bondar I.A., Gavalova R.F., Zenkova E.V. Purtova L.A. Long-term effects of antitumor therapy hematological malignancies. Novosibirsk., 2005, 364 p. (in Russian)

6. Rebrov O.J. Statistical analysis of medical data. M., 2006. 312 p. (in Russian)

7. Samochatova E.V., Shelihova L.N., Belogurova M.B. et al. Combined chemoimmunotherapy of patients with non-Hodgkin lymphomas of mature B cells in age group of 18 years: results of a multicenter study of NHL 2004  with the use of rituximab and modified protokol the NHL BFM 90 // Hematology. 2009. (3). 4-14. (in Russian)

8. Tuzikov F.V., Panin L.E., Tuzikova N.A., Polyakov L.M. Application of the method of small-angle X-ray scattering to assess structural changes in high-density lipoprotein. // Biological membranes. 1996. T.13, № 1. p.71-78. (in Russian)

9. Rumyntceva Y.V., Karachunsky A.I., Aleinikova O.V., et al. Cardiotoxicity chemoradiotherapy of Hodgkin lymphoma in children and adolescents // Hematology. 2010 (1). 31-36. (in Russian)

10. Chernishova AS The use of natural zeolites in the treatment of patients with hematological accompany patients on courses polihimiotrepii: Dis. ... PhD. honey. Sciences. Novosibirsk. 2011. - 159p. (in Russian)

11. Chernishova A.S., Pospelov T.I. Maintenance therapy with the use of natural zeolites in the rehabilitation of cancer patients during himiotreapii // Bul. SB RAMS. 2010. (2). 75-80. (in Russian)

12. Shuykova K.V., Emelina E.I., Gendlin G.E., Storozhakov G.I. Cardiotoxicity of modern chemotherapy drugs // Atmosphere. News cardiology. 2012. (3). 9-19. (in Russian)

13. Baroni S., Scribano D., Zupi C. et al. Prognostic relevance of lipoprotein cholesterol levels in acute lymphocytic and nonlymphocytic leukemia // Acta Haematol. 1996. 96 (1). 24–28.

14. Castelli W.P., Anderson K., Wilson P.W., Levy D. Lipids and risk of coronary heart disease. The Framingham Study // Ann. Epidemiol. 1992. 2. (1-2). 23–8.

15. Reiner Z., Catapano A.L., De Backer G. et al. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS) // Eur. Heart J. 2011. 32. (14). 1769–1818.